Phyathai 2 Hospital
Phyathai 2 Hospital is a Bangkok private hospital within the Phyathai hospital network, associated with Bangkok Dusit Medical Services. In the cosmetic-aesthetic tourism context, its relevance comes from hospital-based elective services, international patient handling, and the credibility that comes from operating inside a larger private healthcare group. Unlike standalone beauty clinics, Phyathai 2 can combine specialist consultation, surgical infrastructure, diagnostics, and post-operative care, making it part of the institutional medical-aesthetic segment.
Profile overview
Phyathai 2 Hospital is a Bangkok private hospital within the Phyathai hospital network, associated with Bangkok Dusit Medical Services. In the cosmetic-aesthetic tourism context, its relevance comes from hospital-based elective services, international patient handling, and the credibility that comes from operating inside a larger private healthcare group. Unlike standalone beauty clinics, Phyathai 2 can combine specialist consultation, surgical infrastructure, diagnostics, and post-operative care, making it part of the institutional medical-aesthetic segment.
Service segments
Cosmetic surgery
Elective aesthetic procedures
Rhinoplasty, double-eyelid, breast augmentation, and facial-contouring procedures targeting international medical-aesthetic tourists; hospital-grade safety with post-operative care.
Dermatology
Aesthetic dermatology
Laser resurfacing, Botox, fillers, and skin treatments in a clinical hospital setting; accessible price points versus standalone clinics with similar safety standards.
GRS/SRS
Gender-affirming surgery
Thailand is globally recognised for gender-reassignment procedures; Phyathai 2's BDMS network provides surgical and anaesthesia depth for complex procedures.
International patients
Medical-tourism handling
Multilingual coordinators, international insurance handling, and concierge services supporting Chinese, Middle Eastern, and Western medical-tourist inbound demand.
Bangkok private hospital peer comparison
Sector positions 2024
Ticker
—
Aesthetic focus
Cosmetic, bariatric
Group
Private
Bumrungrad International
Ticker
SET:BH
Aesthetic focus
Multi-specialty, cosmetic
Group
Listed
PAI Clinic
Ticker
—
Aesthetic focus
GRS/SRS specialist
Group
Private
| Hospital | Ticker | Aesthetic focus | Group |
|---|---|---|---|
| Phyathai 2 Hospital | SET:BCH | Cosmetic, GRS | BDMS / Phyathai network |
| Yanhee Hospital | — | Cosmetic, bariatric | Private |
| Bumrungrad International | SET:BH | Multi-specialty, cosmetic | Listed |
| Samitivej Hospital | SET:BCH | Pediatric, cosmetic | BDMS group |
| PAI Clinic | — | GRS/SRS specialist | Private |
Watchpoints 2025-2026
Market
Chinese cosmetic-tourist recovery
Chinese cosmetic-tourism inbound is recovering post-2022; Phyathai 2 needs Mandarin-capable coordinators and China-specific marketing to capture this high-spend segment.
Competition
Standalone clinic expansion
Dedicated aesthetic clinics multiply in Bangkok with lower overheads; hospitals must prove clinical safety advantage to justify higher pricing versus clinic alternatives.
Regulation
Medical-tourism accreditation
JCI accreditation and Ministry of Public Health licensing are the competitive signals that international patient-flow agents use to vet Thai hospitals for overseas referrals.
Source-pack context
Phyathai 2 Hospital is linked to existing Insight report coverage through tracked source packs. The cited sources provide the current evidence trail for market context, regulatory exposure, operator positioning, or sector structure; exact numeric claims should still be checked against raw snapshots before being surfaced as headline metrics.[, , ]
Deep operating read
Phyathai 2 is a hospital-based elective-care and aesthetic-tourism profile rather than a standalone beauty-clinic story. The source pack frames Thailand's medical-tourism market at USD 8.6B in 2025 and USD 9.5B in 2026, with cosmetic surgery commanding 25% of total medical-tourism spend in 2026. Phyathai 2's operating advantage is clinical infrastructure, diagnostics and post-operative support that can sit above clinic-only providers while remaining below the most globally famous premium hospitals in brand pull.[, , , ]
Execution watchpoints
The watchpoint is international-patient conversion in niches where Thailand already has specialist credibility, including cosmetic and gender-affirming surgery. Grand View cites Thailand's aesthetic-medicine market at USD 1.46B in 2023 with 11.6% CAGR through 2030, while source-pack evidence also covers GRS/SRS leadership and Chinese cosmetic-tourism flow. Phyathai 2 needs visible outcomes, surgeon reputation, language support and aftercare coordination to compete with Yanhee, Bumrungrad and dedicated specialist clinics.[, , , ]
Related Market profiles
Peers, parents, partners, agencies, and other Hospitals & Medical Tourism actors.
Competitor
Bumrungrad Hospital
Thailand's medical-tourism flagship — first Asian hospital JCI-accredited (2002); >60% international-patient revenue mix.
Open Market profile →
Competitor
Bangkok Dusit Medical Services
Thailand's largest listed hospital group — 50+ hospitals across six brand families; > $3.19B FY2024 revenue.
Open Market profile →
Competitor
Bangkok Chain Hospital
Mid-market listed hospital operator — Kasemrad brand across 15+ hospitals; SSS, UCS contract-heavy franchise.
Open Market profile →
Sector peer
Asian Cosmetic Surgery Center
Bangkok cosmetic surgery center serving domestic and international patients.
Open Market profile →
Reports featuring this profile
Thailand Hospital REIT & Asset-Light Healthcare 2027 Market Intelligence
Phyathai group inside BDMS network; benchmark for intra-chain property bundling
Open report →
Sits alongside 4 other Atlas profilesThailand Cosmetic Surgery & Aesthetic Medicine Market Intelligence
BDMS-affiliated cosmetic clinic; mid-premium positioning serving Bangkok metro.
Open report →
Sits alongside 5 other Atlas profilesCosmetic Surgery and Aesthetic Tourism: The Korean-Adjacent Bangkok Cluster
BDMS-affiliated cosmetic-clinic operation.
Open report →
Sits alongside 5 other Atlas profilesRelated Market profiles
competitor
Bumrungrad Hospital
Thailand's medical-tourism flagship — first Asian hospital JCI-accredited (2002); >60% international-patient revenue mix.
competitor
Bangkok Dusit Medical Services
Thailand's largest listed hospital group — 50+ hospitals across six brand families; >THB 110B FY2024 revenue.
competitor
Bangkok Chain Hospital
Mid-market listed hospital operator — Kasemrad brand across 15+ hospitals; SSS, UCS contract-heavy franchise.